PDMR dealings
Released : Aug 21, 2018
Tiziana Life Sciences plc
(Incorporated in
PDMR dealings
Tiziana Life Sciences plc (LSE: TILS) (the "Company") announces that on 20 August 2018, Dr Shailubhai Kunwar, Chief Executive Officer and Tiziano Lazzaretti, Chief Financial Officer bought shares in the Company as follows :
The information set out below is provided in accordance with the requirements of Regulation 19(3) of the EU Market Abuse Regulation No 596/2014:
|
1. |
Details of PDMR / person closely associated |
|||
|
a) |
Name |
Dr Shailubhai Kunwar |
||
|
2. |
Reason for the notification: On market acquisition |
|||
|
a) |
Position / status |
Chief Executive Officer |
||
|
b) |
Initial notification /amendment |
Initial notification |
||
|
3. |
Details of the issuer |
|||
|
a) |
Name |
Tiziana Life Sciences plc |
||
|
b) |
LEI |
213800CED47HI8PIOB36 |
||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
|
a) |
Description of the financial instrument |
Ordinary Shares of 3p each |
||
|
b) |
Identification code of the Financial Instrument |
ISIN for Tiziana Life Sciences plc: GB00BKWNZY55 |
||
|
c) |
Nature of the transaction |
Acquisition of shares |
||
|
d) |
Price(s) and volume(s) |
Price: |
||
|
e) |
Aggregated information - Aggregated volume - Price |
5,000
|
||
|
f) |
Date of the transaction |
20 August 2018 |
||
|
g) |
Place of the transaction |
XLON |
||
|
1. |
Details of PDMR / person closely associated |
|||
|
a) |
Name |
Tiziano Lazzaretti |
||
|
2. |
Reason for the notification: On market acquisition |
|||
|
a) |
Position / status |
Chief Financial Officer |
||
|
b) |
Initial notification /amendment |
Initial notification |
||
|
3. |
Details of the issuer |
|||
|
a) |
Name |
Tiziana Life Sciences plc |
||
|
b) |
LEI |
213800CED47HI8PIOB36 |
||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
|
a) |
Description of the financial instrument |
Ordinary Shares of 3p each |
||
|
b) |
Identification code of the Financial Instrument |
ISIN for Tiziana Life Sciences plc: GB00BKWNZY55 |
||
|
c) |
Nature of the transaction |
Acquisition of shares |
||
|
d) |
Price(s) and volume(s) |
Price: |
||
|
e) |
Aggregated information - Aggregated volume - Price |
2,000
|
||
|
f) |
Date of the transaction |
20 August 2018 |
||
|
g) |
Place of the transaction |
XLON |
||
Neither Dr Shailubhai nor Mr Lazzaretti were holders of shares in the Company prior to the acquisitions set out above.
For more information go to http://www.tizianalifesciences.com
Contacts:
|
Tiziana Life Sciences plc Gabriele Cerrone, Chairman and founder
|
+44 (0)20 7493 2853 |
|
Cairn Financial Advisers LLP (Nominated adviser) Liam Murray / Jo Turner |
+44 (0)20 7213 0883 |
|
Stockdale Securities (Broker) Antonio Bossi / Andy Crossley
|
+44 (0)20 7601 6100 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the